Male or Female between the ages of 18-65 years, inclusive |
Photo Identification |
In evaluation for Roux-en-Y Gastric Bypass or Sleeve Gastrecomy as primary procedure |
Surgery Department |
Planning to be available for two years of follow-up after surgery |
Self-report |
Exclusion Criteria |
Method of Assessment |
Alcohol or substance use disorder in the past year |
Structured Interview |
Severe psychiatric disorder that may affect the ability of the participant’s ability to comply with the protocol |
Structured interview |
Tobacco use in the prior year |
Self-report |
Current medication known to significantly influence gastrointestinal transit time (e.g., opioids, glp-1 agonists, metoclopramide) or is being taken routinely for weight loss (e.g., phentermine, topiramate) |
Medical History |
Use of any oral or injectable antibiotic in the past month |
Medical History |
Use of commercially available prebiotic or probiotic in the past month |
Medical History |
History of significant intestinal disease or disorder that would influence the microbiome (e.g., Crohn’s Disease, etc.) |
Medical History |
History of significant gastrointestinal surgery that would influence the microbiome, not including cholecystectomy or appendectomy |
Medical History |
Inability to engage in physical activity or dietary monitoring or any medical condition that would put the participant at risk in the study |
Self-report |
Positive urine drug screen for a non-prescribed medication |
Urine drug screen |
Pregnancy or breast feeding |
Self-report |